Compare Cross-Linking Systems

6 Products

reset all

At-a-Glance

Description

FDA

CE Mark

Active Ingredients

Application

Illumination

Procedure Time

Spot size

Status

Strength

Wavelength

remove

KXL System

Avedro, Inc.

Built-in touchscreen display
Used with: VibeX Treatment Activation, VibeX Rapid, ParaCel Treatment Activation

The KXL System achieves Accelerated Cross-Linking in minutes by increasing the UVA power and reducing the exposure time while maintaining the same total energy on the eye as standard cross-linking.

Yes

—

Pulsed or Continuous Wave

—

Minutes

—

4-11 mm

—

370 nm

—

remove

KXL II System

Avedro, Inc.

Built-in touchscreen display with fully customizable interface
Used with: VibeX Treatment Activation, VibeX Rapid, ParaCel Treatment Activation

Avedro has developed the KXL II System to integrate patient topography with real-time eye tracking, real-time riboflavin dosimetry imaging, and programmable UVA illumination patterns to provide a customizable procedure to the individual patient.

Not specified

Yes

—

Pulsed or Continuous Wave

—

Minutes

—

4-11 mm

—

Not specified

—

remove

Mosaic

Avedro, Inc.

Built-in display fully-customizable touchscreen display
Used with: VibeX Treatment Activation, VibeX Rapid, ParaCel Treatment Activation

The Mosaic System allows patterned, topography-guided Accelerated Cross-Linking in just minutes by increasing the UVA power and reducing the exposure time while maintaining the same total energy on the eye as standard cross-linking.

Not specified

Yes

—

Ultra-violet UVA light

—

Minutes

—

Not specified

—

Not specified

—

remove

IV-MED 80

iVeena Delivery Systems

Mechanism of Action: It is believed that lysyl oxidases, a family comprising LOX and four LOX-like enzymes (LOXL1-4), catalyze the formation of collagen crosslinks and elastin and are implicated in the age-related corneal stiffening synonymous with keratoconus.
Dosage: One drop twice per day.

IVMED-80 is the first eye-drop, non-surgical, non-laser treatment for medical crosslinking of the cornea. The FDA granted orphan drug designation for IVMED-80 for the treatment of keratoconus in November 2017.

Orphan Drug Designation

Not specified

Topical

—

Prescription

—

Not specified

—

remove

CBM Vega Cross Linking System

bon Optic

Integrated control monitor and color camera
54 mm working distance
Used with: Ricrolin, Ricrolin TE, Ricrolin PLUS

The CBM Vega has been developed for UV-crosslinking (CVL) of progressive keratoconus. Advanced iontophoresis technology allows for comfort for you and your patients, and the system guides you with visual and audible instructions through the treatment process.

Not specified

Yes

—

Continuous Wave

—

9 minutes

—

4-11 mm

—

370 nm

—

remove

LIGHTLink-CXL

LightMed Corporation

Full customizable treatment parameters for procedure time, power, spot size, and mode of irradiation delivery
Integrated high-resolution auto-focusing camera
11.6 inch touchscreen color LCD with built in PC

Supplying a plug and treat turnkey solution, the LIGHTLink-CXL is designed with laser-like mechanisms & functionality, resulting in safety and clinical effectiveness.

Not specified

Yes

—

UV-A-LED Cluster

—

45 minutes

—

4-11 mm

—

365 nm ±5nm

—

This content is intended for health care professionals and providers only. The information contained on Beye.com, including text, graphics, images, and interactive activities, is for informational purposes only, and is not intended to be a substitute for professional medical advice. Beye LLC, via its Editors and Publisher, accepts no responsibility for any injury or damage to persons or property occasioned through the implementation of any ideas or use of any product described herein. Although great care is taken to ensure that all information is accurate, it is recommended that readers seek independent verification of advice on drugs and other product usage, surgical techniques and clinical processes prior to their use. References made in article may indicate usage of medical equipment or drugs at dosages, for periods of time, and in combination not included in the current prescribing information. Inclusion of advertising materials on the website thereof, does not constitute and representation or guarantee by Beye LLC of the quality of such products, or of the claims made.